Synonyms:VE-822, 1232416-25-9, Berzosertib, VX-970, VE822, VX970, VE 822, Berzosertib [USAN], VE-822 (VX-970), 5-(4-(isopropylsulfonyl)phenyl)-3-(3-(4-((methylamino)methyl)phenyl)isoxazol-5-yl)pyrazin-2-amine, L423PRV3V3, 3-(3-{4-[(METHYLAMINO)METHYL]PHENYL}-1,2-OXAZOL-5-YL)-5-[4-(PROPANE-2-SULFONYL)PHENYL]PYRAZIN-2-AMINE, M6620, 2-Pyrazinamine, 3-(3-(4-((methylamino)methyl)phenyl)-5-isoxazolyl)-5-(4-((1-methylethyl)sulfonyl)phenyl)-, 3-[3-[4-(methylaminomethyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine, M-6620, BDBM50226746, 2-Pyrazinamine, 3-[3-[4-[(methylamino)methyl]phenyl]-5-isoxazolyl]-5-[4-[(1-methylethyl)sulfonyl]phenyl]-, 3-(3-(4-((METHYLAMINO)METHYL)PHENYL)-1,2-OXAZOL-5-YL)-5-(4-(PROPANE-2-SULFONYL)PHENYL)PYRAZIN-2-AMINE, 3-[3-[4-[(Methylamino)methyl]phenyl]-5-isoxazolyl]-5-[4-[(1-methylethyl)sulfonyl]phenyl]-2-pyrazinamine, 5-(4-(isopropylsulfonyl)phenyl)-3-(3-(4-((methylamino)methyl)phenyl)isoxazol-5-yl)pyrazin-2-amine., UNII-L423PRV3V3, 3-(3-(4-((Methylamino)methyl)phenyl)-5-isoxazolyl)-5-(4-((1-methylethyl)sulfonyl)phenyl)-2-pyrazinamine, VX-970;Berzosertib, BERZOSERTIB [INN], Berzosertib (USAN/INN), Berzosertib (VE-822), AGN-PC-0CXKB3, BERZOSERTIB [WHO-DD], GTPL8003, SCHEMBL3061890, CHEMBL3989870, EX-A529, CHEBI:131166, BDBM350085, DTXSID601025940, HMS3653C05, HMS3747I11, BCP07948, MFCD27976794, NSC777718, s7102, US10208027, Compound II-1, US10208027, Compound II-2, US10208027, Compound II-3, US10208027, Compound II-4, VX 970, AKOS025404905, CCG-264673, CS-1861, DB11794, NSC-777718, SB17265, NCGC00386313-07, AC-32951, AS-17041, DA-46989, HY-13902, FT-0700136, SW220202-1, A13289, D11148, A857986, Q27089129, 5-(4-isopropylsulfonylphenyl)-3-[3-[4-(methylaminomethyl)phenyl]isoxazol-5-yl]pyrazin-2-amine, Synthesis of 3-[3-[4-[dideuterio(methylamino)methyl]phenyl]isoxazol-5-yl]-5-(4-isopropylsulfonylphenyl)pyrazin-2-amine
Id:59472121
Description:nan